赢8娱乐糖果配对游戏-官方网站[welcome]


+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

List of PDF Full Texts available from EurekaMag Chapter 68054

Chapter 68054 contains a list of PDF Full Texts available from EurekaMag.





Targeting of Metabotropic Glutamate Receptors for the Treatment of Schizophrenia
, Current Pharmaceutical Design 17(2): 94-102 (2011)

The Role of Coagulation in Chronic Inflammatory Disorders: A Jack of All Trades
, Current Pharmaceutical Design 17(1): 9-16 (2011)

The Role of the Pacap Signaling System in Depression
, Current Pharmaceutical Design 17(10): 990-1001 (2011)

Protective Effects of Chronic Green Tea Consumption on Age-related Neurodegeneration
, Current Pharmaceutical Design 18(1): 4-14 (2012)

Role of the Renin-Angiotensin-Aldosterone System in the Pathogenesis of Atherosclerosis
, Current Pharmaceutical Design 18(7): 981-1004 (2012)

MicroRna Dysregulation in Gastric Cancer
, Current Pharmaceutical Design 19(7): 1273-1284 (2012)

MicroRna Dysregulation in Esophageal Neoplasia: The Biological Rationale for Novel Therapeutic Options
, Current Pharmaceutical Design 19(7): 1236-1241 (2012)

The Role of microRnas in the Pathogenesis and Treatment of Hematopoietic Malignancies
, Current Pharmaceutical Design 19(7): 1201-1210 (2012)

Therapeutically Targeting MicroRnas in Liver Cancer
, Current Pharmaceutical Design 19(7): 1180-1191 (2012)

The Expression Patterns and Clinical Significance of microRnas in Liver Diseases and Hepatocellular Carcinoma
, Current Pharmaceutical Design 19(7): 1262-1272 (2012)

Effect of Fibrin-binding Synthetic Oligopeptide on the Healing of Full-thickness Skin Wounds in Streptozotocin-induced Diabetic Rats
, Current Pharmaceutical Design 19(7): 1321-1328 (2012)

MicroRnas: Small Molecules with a Potentially Role in Oral Squamous Cell Carcinoma
, Current Pharmaceutical Design 19(7): 1285-1291 (2012)

MicroRnas and Esophageal Cancer - Implications for Pathogenesis and Therapy
, Current Pharmaceutical Design 19(7): 1211-1226 (2012)

Antimycobacterial Activity of Quaternary Pyridinium Salts and Pyridinium N-oxides - Review
, Current Pharmaceutical Design 19(7): 1343-1355 (2012)

MiRnas in Gastrointestinal and Liver Cancers: Their Perspectives and Clinical Applications
, Current Pharmaceutical Design 19(7): 1301-1310 (2012)

MicroRnas (miRnas) in Colorectal Cancer: From Aberrant Expression Towards Therapy
, Current Pharmaceutical Design 19(7): 1242-1252 (2012)

MicroRna Involvement in Gastrointestinal Stromal Tumor Tumorigenesis
, Current Pharmaceutical Design 19(7): 1227-1235 (2012)

Epigenetic Deregulation of MicroRnas: New Opportunities to Target Oncogenic Signaling Pathways in Hepatocellular Carcinoma
, Current Pharmaceutical Design 19(7): 1192-1200 (2012)

Glycine Reuptake Inhibition as a New Therapeutic Approach in Schizophrenia: Focus on the Glycine Transporter 1 (GlyT1)
, Current Pharmaceutical Design 19(7): 1311-1320 (2012)

MicroRna in the Pathogenesis and Prognosis of Esophageal Cancer
, Current Pharmaceutical Design 19(7): 1292-1300 (2012)

Roles of miRna in the Initiation and Development of Colorectal Carcinoma
, Current Pharmaceutical Design 19(7): 1253-1261 (2012)

The Interplay between the Gut Immune System and Microbiota in Health and Disease: Nutraceutical Intervention for Restoring Intestinal Homeostasis
, Current Pharmaceutical Design 19(7): 1329-1342 (2012)

Role of Nitric Oxide in the Central Interferon-alpha-induced Inhibition of Gastric Acid Secretion in Rats
, Current Pharmaceutical Design 19(1): 11-16 (2012)

Gastric Mucosal Protection And Central Nervous System
, Current Pharmaceutical Design 19(1): 34-39 (2012)

Antimicrobial Peptides and Colitis
, Current Pharmaceutical Design 19(1): 40-47 (2012)

Discovery of Lansoprazole and its Unique Pharmacological Properties Independent from Anti-secretory Activity
, Current Pharmaceutical Design 19(1): 67-75 (2012)

Central Actions of Somatostatin-28 and Oligosomatostatin Agonists to Prevent Components of the Endocrine, Autonomic and Visceral Responses to Stress Through Interaction with Different Somatostatin Receptor Subtypes
, Current Pharmaceutical Design 19(1): 98-105 (2012)

Chemoprevention of Cancers in Gastrointestinal Tract with Cyclooxygenase 2 Inhibitors
, Current Pharmaceutical Design 19(1): 115-125 (2012)

Taming the Irritable Bowel
, Current Pharmaceutical Design 19(1): 142-156 (2012)

HtrA Protease Family as Therapeutic Targets
, Current Pharmaceutical Design 19(6): 977-1009 (2012)

The Opioid Receptor and Ligands Acting at the Opioid Receptor, as Therapeutics and Potential Therapeutics
, Current Pharmaceutical Design 19(42): 7415-7434 (2014)

Hybrid Opioid/Non-Opioid Ligands in Pain Research
, Current Pharmaceutical Design 19(42): 7435-7450 (2014)

Biomarkers Predicting a Need for Intensive Treatment in Patients with Early Arthritis
, Current Pharmaceutical Design 21(2): 170-181 (2014)

Rheumatoid Arthritis: Genetic Variants as Biomarkers of Cardiovascular Disease
, Current Pharmaceutical Design 21(2): 182-201 (2014)

Quorum Sensing and Biofilms in the Pathogen, Streptococcus pneumoniae
, Current Pharmaceutical Design 21(1): 25-30 (2014)

Current and Future Approaches to the Prevention and Treatment of Staphylococcal Medical Device-Related Infections
, Current Pharmaceutical Design 21(1): 100-113 (2014)

Potential Application of Antimicrobial Peptides in the Treatment of Bacterial Biofilm Infections
, Current Pharmaceutical Design 21(1): 67-84 (2014)

Targeting Cyclic di-Gmp Signalling: A Strategy to Control Biofilm Formation?
, Current Pharmaceutical Design 21(1): 12-24 (2014)

Clinical Applications of Choline Pet/Ct in Brain Tumors
, Current Pharmaceutical Design 21(1): 121-127 (2014)

Novel Dual Small-Molecule Hiv inhibitors: Scaffolds and Discovery Strategies
, Current Pharmaceutical Design 21(7): 950-962 (2014)

The Apoe Genotype: Modification of Therapeutic Responses in Alzheimer's Disease
, Current Pharmaceutical Design 21(1): 114-120 (2014)

Antihypertensive Drugs Metabolism: An Update to Pharmacokinetic Profiles and Computational Approaches
, Current Pharmaceutical Design 21(6): 806-822 (2014)

Targeting Cardiomyocyte Ca 2+ Homeostasis in Heart Failure
, Current Pharmaceutical Design 21(4): 431-448 (2014)

Markers of Atherosclerotic Disease: What do they Mean? Current Opinion and Future Trends
, Current Pharmaceutical Design 22(1): 7-17 (2015)

Air Pollution Exposure and Blood Pressure: An Updated Review of the Literature
, Current Pharmaceutical Design 22(1): 28-51 (2015)

Adipose Tissue Oxygenation in Obesity: A Matter of Cardiovascular Risk?
, Current Pharmaceutical Design 22(1): 68-76 (2015)





赢8娱乐糖果配对游戏 <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <文本链> <文本链> <文本链> <文本链> <文本链> <文本链>